Home/Filings/4/A/0000915389-23-000128
4/A//SEC Filing

Killian Christopher Moore 4/A

Accession 0000915389-23-000128

CIK 0000915389other

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 4:01 PM ET

Size

5.5 KB

Accession

0000915389-23-000128

Insider Transaction Report

Form 4/AAmended
Period: 2022-02-10
Killian Christopher Moore
SVP, CTO & Sust. Ofc,
Transactions
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2022-02-103,4203,440 total
    Exercise: $72.92From: 2021-10-15Exp: 2029-10-15Common Stock (3,420 underlying)
Footnotes (1)
  • [F1]Form 4 filed on February 11, 2022 incorrectly reported Item 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) as 6,869. The correct balance should be 3,440. This Amendment is filed to correct this balance only.

Issuer

EASTMAN CHEMICAL CO

CIK 0000915389

Entity typeother

Related Parties

1
  • filerCIK 0001866834

Filing Metadata

Form type
4/A
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 4:01 PM ET
Size
5.5 KB